HERON THERAPEUTICS INC (HRTX) Institutional Ownership

HRTX is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.37M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $1.37M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's HRTX position is now estimated to be worth approximately $665,497.59, representing an estimated loss of -51.59% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward HERON THERAPEUTICS INC (HRTX).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$1,374,8121,718,300
Q4 20251$2,490,6701,915,900
Q3 20251$3,597,2992,854,999
Q2 20251$5,566,9322,689,339
Q1 20251$5,003,9002,274,500
Q4 20241$1,818,8641,188,800
Q3 20241$3,996,3142,008,198
Q2 20241$6,978,3001,993,800
Q1 20241$6,6662,406,486
Q4 20231$3,2021,883,300
Q3 20231$300291,300
Q2 20231$1,2291,059,100

Related HRTX Institutional Insights: